Tag: Stephen Van Deventer

November 13, 2018

PreveCeutical Announces LOI with Crushedit LLC to Supply CBD Isolate for Expected Sale Proceeds of $16.25 Million

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H), (the "Company" or "PreveCeutical") announces that it has entered into a non-binding letter of intent dated November 9,...
October 31, 2018

PreveCeutical Provides Update on Visit to Penta 5 Group’s Facility for Due Diligence on Proposed Acquisition

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical"), provides an update on its recent due diligence trip (the "Due...
October 30, 2018

PreveCeutical Holds Intensive Workshop to Advance Dual Gene Therapy Research Program for Type 2 Diabetes and Obesity

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical"), is pleased to announce that its research team at the University of Queensland,...
September 26, 2018

PreveCeutical Enters into Development Agreement with Asterion Cannabis Inc. to Develop Medicinal Cannabinoid Products

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) ("PreveCeutical"), and Asterion Cannabis Inc. ("Asterion") announce that they have entered into a development...
September 4, 2018

Asterion Enters Consulting Agreement with White Sheep Services Corp. and Appoints Hamish Sutherland as COO

Asterion Cannabis Inc. ("Asterion" or the "Company"), is pleased to announce that it has entered into a consulting agreement with...
August 22, 2018

PreveCeutical Provides Corporate Update

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical"), is pleased to provide an update on the Company's progress in its ongoing corporate...